Please note that this product was withdrawn from the Union Register of orphan medicinal products in November 2019 on request of the sponsor.
On 16 December 2014, orphan designation (EU/3/14/1405) was granted by the European Commission to TxCell, France, for autologous collagen type II-specific regulatory T cells for the treatment of non-infectious uveitis.
Autologous collagen type II-specific regulatory T cells
|Disease / condition||
Treatment of non-infectious uveitis
|Date of first decision||
|EU designation number||
Review of designation
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.